National TB Control Program,pakista Pharmaceutical Import Profile — Pakistan (DGFT 2022–2026)

Name: National TB Control Program,pakista Pharmaceutical Import Records from India — 2 Products, $650.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

National TB Control Program,pakista — Pharmaceutical Importer Profile (2026) | 2 Products, $650.0K Trade | TransData Nexus

Who Are the Verified Indian Suppliers to National TB Control Program,pakista?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$373.0K	11	100.0%

National TB Control Program,pakista sources from 1 verified Indian supplier across 11 distinct formulations. The sourcing is highly concentrated — Macleods Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does National TB Control Program,pakista Import?

Formulation	Value	Ships
Ethambutol hcl 100MG dispersible tablets(3432 pks) (ps. 10 x 10)	$50.0K	1
Rifampicin 150MG+ isoniazid 75MG+ pyrazinamide 400MG+ ethambutol 275MG tablets (12627 pks) (ps. 24 x 28)	$50.0K	1
Rifampicin 150MG+isoniazid 75MG+pyrazinamide 400 MG+ethambutol 275MG tablets (12965 pks) (ps. 24 x 28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG dispersible tablets(43768 pks)(ps.3 x28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG dispersible tablets(43769 pks)(ps.3 x28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG/pyrazinamide 150MG disp tabs(22473 pks)(ps.3 x28)	$50.0K	1
Rifampicin 75MG/isoniazid 50MG/pyrazinamide 150MG disp tabs(22474 pks)(ps.3 x28)	$50.0K	1
Rifampicin 150MG+ isoniazid 75MG+ pyrazinamide 400MG+ ethambutol 275MG tablets (337 pks) (ps. 24 x 28)	$23.0K	1

National TB Control Program,pakista imports 11 distinct pharmaceutical formulations. Showing top 11 by value. For full formulation-level data, contact TransData Nexus.

What Products Does National TB Control Program,pakista Import?

Top Products by Import Value

1Pyrazinamide$350.0K 2Ethambutol$300.0K

National TB Control Program,pakista Therapeutic Categories — 1 Specializations

National TB Control Program,pakista imports across 1 therapeutic categories, with Tuberculosis Medications (100.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Tuberculosis Medications

2 products · 100.0% · $650.0K

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Pyrazinamide	Tuberculosis Medications	$350.0K	7	0.0%	10
2	Ethambutol	Tuberculosis Medications	$300.0K	6	0.0%	16

Key Metrics

Total Import Value$650.0K

Products2

Shipments13

Categories1

CountryPakistan

#1 Rankings0

Indian Suppliers1

Formulations11

Top Categories

Tuberculosis Medications100.0%

Indian Suppliers

Last updated: March 28, 2026

National TB Control Program,pakista — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The National TB Control Program (NTP) of Pakistan is a government initiative operating under the Ministry of National Health Services, Regulations, and Coordination. Its mission is to eliminate tuberculosis (TB) from the country by providing free diagnostic and treatment services across a network of over 1,700 TB care facilities in both public and private sectors. In 2022, the program successfully treated more than 424,000 TB cases, demonstrating its significant role in Pakistan's healthcare system. (cmu.gov.pk)

As a government entity, NTP is not a commercial pharmaceutical buyer or importer. Instead, it collaborates with various stakeholders, including international organizations and local suppliers, to procure the necessary medications and supplies for TB control. The program's procurement processes are designed to ensure the availability of quality-assured TB medications, aligning with its goal of providing effective and free TB care to the population.

2Distribution Network

NTP's distribution network spans the entire country, encompassing over 1,700 TB care facilities. These facilities are strategically located in both urban and rural areas to ensure equitable access to TB services. The program's logistics capabilities include a robust supply chain management system that coordinates the procurement, storage, and distribution of TB medications and diagnostic tools. This system is designed to prevent stockouts and ensure timely delivery of essential TB care services across Pakistan. (cmu.gov.pk)

Importing Pharmaceuticals into Pakistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Pakistan

1Regulatory Authority & Framework

The Drug Regulatory Authority of Pakistan (DRAP) is the national regulatory body responsible for ensuring the quality, safety, and efficacy of therapeutic goods in Pakistan. DRAP oversees the import and export of pharmaceutical products, including TB medications, to prevent the infiltration of substandard and falsified products into the supply chain. The regulatory framework governing pharmaceutical imports includes the Drugs Act, 1976, and the DRAP Act, 2012, which outline the procedures and requirements for the importation of therapeutic goods. (dra.gov.pk)

2Import Licensing & GMP

Importers of pharmaceutical products in Pakistan must obtain a Drug Import License (DIL) from DRAP. This license is granted upon submission of an application through DRAP's online portal, accompanied by the requisite documents. Additionally, imported pharmaceutical products must comply with Good Manufacturing Practice (GMP) standards recognized by DRAP. GMP certification ensures that products are consistently produced and controlled according to quality standards, which is essential for maintaining the safety and efficacy of therapeutic goods in the Pakistani market. (dra.gov.pk)

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to verify their quality, safety, and efficacy. Stability studies are also required to ensure that products maintain their quality throughout their shelf life. Labeling requirements include the use of the Urdu language for all labeling and packaging materials, ensuring that information is accessible to the general population. Serialization mandates are in place to enhance traceability and prevent counterfeit products from entering the supply chain. These measures are part of DRAP's regulatory framework to ensure the integrity of pharmaceutical products in Pakistan. (dra.gov.pk)

4Recent Regulatory Changes

In March 2026, DRAP published the draft Therapeutic Goods (Import and Export) Rules, 2026, for public consultation. These proposed rules aim to update and streamline the import and export procedures for therapeutic goods, including pharmaceutical products. The draft rules emphasize compliance with national quality standards and regulations, enhancing the regulatory oversight of therapeutic goods entering and leaving Pakistan. Stakeholders are invited to submit objections or suggestions within 14 days of the publication for consideration by DRAP. (dra.gov.pk)

TransData Nexus Research · Pakistan regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: National TB Control Program,pakista identified across shipments using consignee name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as National TB Control Program,pakista's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 13 individual customs records matching National TB Control Program,pakista.
5.Supplier Verification: National TB Control Program,pakista sources from 1 verified Indian suppliers across 11 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

1 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

National TB Control Program,pakista

National TB Control Program,pakista — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to National TB Control Program,pakista?

What Formulations Does National TB Control Program,pakista Import?

What Products Does National TB Control Program,pakista Import?

Top Products by Import Value

National TB Control Program,pakista Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

National TB Control Program,pakista — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — National TB Control Program,pakista

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Pakistan — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

National TB Control Program,pakista — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to National TB Control Program,pakista

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — National TB Control Program,pakista

What products does National TB Control Program,pakista import from India?

Who supplies pharmaceuticals to National TB Control Program,pakista from India?

What is National TB Control Program,pakista's total pharmaceutical import value?

What therapeutic categories does National TB Control Program,pakista focus on?

Get Full National TB Control Program,pakista Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology